_id

690daccfccc777a4e85d09b9

Ticker

AKRO

Name

Akero Therapeutics Inc

Exchange

NASDAQ

Address

601 Gateway Boulevard, South San Francisco, CA, United States, 94080

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://akerotx.com

Description

Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Last Close

54.65

Volume

1041259

Current Price

54.65

Change

0

Last Updated

2025-11-28T12:04:58.950Z

Image

data:image/webp;base64,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

Ipo Date

2019-06-20T00:00:00.000Z

Market Cap

4473884160

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7015307692307693

Sentiment Sources

13

Rating

4.75

Target Price

56

Strong Buy

9

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

90236000

Operating Income

-90236000

Interest Expense

1092000

Pretax Income

-81566000

Net Income

-81566000

Eps

-0.9946070437020696

Dividends Per Share

-

Shares Outstanding

82316179

Income Tax Expense

-

EBITDA

-80469500

Operating Margin

-

Total Other Income Expense Net

8670000

Cash

176032000

Short Term Investments

561794000

Receivables

-

Inventories

-

Total Current Assets

754535000

Property Plant Equipment

552000

Total Assets

1005577000

Payables

20399000

Short Term Debt

875000

Long Term Debt

-

Total Liabilities

47940000

Equity

957637000

Depreciation

179000

Change In Working Capital

-992000

Cash From Operations

-67171000

Capital Expenditures

0

Cash From Investing

56781000

Cash From Financing

-34027000

Net Change In Cash

-44417000

PE

-

PB

4.68001110185801

ROE

-8.517423616673124

ROA

-8.111362928945272

FCF

-67171000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

90236000

Quarters > 0 > income Statement > operating Income

-90236000

Quarters > 0 > income Statement > interest Expense

1092000

Quarters > 0 > income Statement > pretax Income

-81566000

Quarters > 0 > income Statement > net Income

-81566000

Quarters > 0 > income Statement > eps

-0.9946070437020696

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

82008267

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-80469500

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

8670000

Quarters > 0 > balance Sheet > cash

176032000

Quarters > 0 > balance Sheet > short Term Investments

561794000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

754535000

Quarters > 0 > balance Sheet > property Plant Equipment

552000

Quarters > 0 > balance Sheet > total Assets

1005577000

Quarters > 0 > balance Sheet > payables

20399000

Quarters > 0 > balance Sheet > short Term Debt

875000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

47940000

Quarters > 0 > balance Sheet > equity

957637000

Quarters > 0 > cash Flow > net Income

-81566000

Quarters > 0 > cash Flow > depreciation

179000

Quarters > 0 > cash Flow > change In Working Capital

-992000

Quarters > 0 > cash Flow > cash From Operations

-67171000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

56781000

Quarters > 0 > cash Flow > cash From Financing

-34027000

Quarters > 0 > cash Flow > net Change In Cash

-44417000

Quarters > 0 > ratios > PE

-0.9946070437020696

Quarters > 0 > ratios > PB

4.68001110185801

Quarters > 0 > ratios > ROE

-8.517423616673124

Quarters > 0 > ratios > ROA

-8.111362928945272

Quarters > 0 > ratios > FCF

-67171000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

80873000

Quarters > 1 > income Statement > operating Income

-80873000

Quarters > 1 > income Statement > interest Expense

1172000

Quarters > 1 > income Statement > pretax Income

-70505000

Quarters > 1 > income Statement > net Income

-70505000

Quarters > 1 > income Statement > eps

-0.8627484504148223

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

81721387

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-69333000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

10368000

Quarters > 1 > balance Sheet > cash

220449000

Quarters > 1 > balance Sheet > short Term Investments

521866000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

764600000

Quarters > 1 > balance Sheet > property Plant Equipment

621000

Quarters > 1 > balance Sheet > total Assets

1109152000

Quarters > 1 > balance Sheet > payables

13249000

Quarters > 1 > balance Sheet > short Term Debt

14657000

Quarters > 1 > balance Sheet > long Term Debt

22160000

Quarters > 1 > balance Sheet > total Liabilities

83333000

Quarters > 1 > balance Sheet > equity

1025819000

Quarters > 1 > cash Flow > net Income

-70505000

Quarters > 1 > cash Flow > depreciation

-2674000

Quarters > 1 > cash Flow > change In Working Capital

15680000

Quarters > 1 > cash Flow > cash From Operations

-48246000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

79340000

Quarters > 1 > cash Flow > cash From Financing

3433000

Quarters > 1 > cash Flow > net Change In Cash

34527000

Quarters > 1 > ratios > PE

-0.8627484504148223

Quarters > 1 > ratios > PB

4.3536664845845126

Quarters > 1 > ratios > ROE

-6.873044854891555

Quarters > 1 > ratios > ROA

-6.356658059490494

Quarters > 1 > ratios > FCF

-48246000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

80882000

Quarters > 2 > income Statement > operating Income

-80882000

Quarters > 2 > income Statement > interest Expense

1154000

Quarters > 2 > income Statement > pretax Income

-70725000

Quarters > 2 > income Statement > net Income

-70725000

Quarters > 2 > income Statement > eps

-0.8991613408705832

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

78656629

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-69566500

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

10157000

Quarters > 2 > balance Sheet > cash

185922000

Quarters > 2 > balance Sheet > short Term Investments

500371000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

713151000

Quarters > 2 > balance Sheet > property Plant Equipment

689000

Quarters > 2 > balance Sheet > total Assets

1155843000

Quarters > 2 > balance Sheet > payables

10831000

Quarters > 2 > balance Sheet > short Term Debt

7309000

Quarters > 2 > balance Sheet > long Term Debt

28811000

Quarters > 2 > balance Sheet > total Liabilities

71997000

Quarters > 2 > balance Sheet > equity

1083846000

Quarters > 2 > cash Flow > net Income

-70725000

Quarters > 2 > cash Flow > depreciation

-2285000

Quarters > 2 > cash Flow > change In Working Capital

-3606000

Quarters > 2 > cash Flow > cash From Operations

-67664000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-482183000

Quarters > 2 > cash Flow > cash From Financing

395531000

Quarters > 2 > cash Flow > net Change In Cash

-154316000

Quarters > 2 > ratios > PE

-0.8991613408705832

Quarters > 2 > ratios > PB

3.9660475518200924

Quarters > 2 > ratios > ROE

-6.525373530925981

Quarters > 2 > ratios > ROA

-6.118910613292636

Quarters > 2 > ratios > FCF

-67664000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

4000

Quarters > 3 > income Statement > cost Of Revenue

2000

Quarters > 3 > income Statement > gross Profit

2000

Quarters > 3 > income Statement > operating Expenses

78025000

Quarters > 3 > income Statement > operating Income

-78025000

Quarters > 3 > income Statement > interest Expense

1200000

Quarters > 3 > income Statement > pretax Income

-70024000

Quarters > 3 > income Statement > net Income

-70024000

Quarters > 3 > income Statement > eps

-0.9922122588346021

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

70573609

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-68809000

Quarters > 3 > income Statement > operating Margin

-1950625

Quarters > 3 > income Statement > total Other Income Expense Net

8001000

Quarters > 3 > balance Sheet > cash

340238000

Quarters > 3 > balance Sheet > short Term Investments

402840000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

770380000

Quarters > 3 > balance Sheet > property Plant Equipment

755000

Quarters > 3 > balance Sheet > total Assets

825886000

Quarters > 3 > balance Sheet > payables

9027000

Quarters > 3 > balance Sheet > short Term Debt

631000

Quarters > 3 > balance Sheet > long Term Debt

35297000

Quarters > 3 > balance Sheet > total Liabilities

75774000

Quarters > 3 > balance Sheet > equity

750112000

Quarters > 3 > cash Flow > net Income

-70024000

Quarters > 3 > cash Flow > depreciation

15000

Quarters > 3 > cash Flow > change In Working Capital

-1389000

Quarters > 3 > cash Flow > cash From Operations

-67090000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

15272000

Quarters > 3 > cash Flow > cash From Financing

75991000

Quarters > 3 > cash Flow > net Change In Cash

24173000

Quarters > 3 > ratios > PE

-0.9922122588346021

Quarters > 3 > ratios > PB

5.141695815891493

Quarters > 3 > ratios > ROE

-9.335139285866644

Quarters > 3 > ratios > ROA

-8.47865201734864

Quarters > 3 > ratios > FCF

-67090000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-16772.5

Quarters > 3 > health Score

30

Valuation > metrics > PE

-0.9946070437020696

Valuation > metrics > PB

4.68001110185801

Valuation > final Score

33.199888981419896

Valuation > verdict

56.0% Overvalued

Profitability > metrics > ROE

-8.517423616673124

Profitability > metrics > ROA

-10.810101585744862

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.05006072238228055

Risk > metrics > Interest Coverage

-82.63369963369964

Risk > final Score

-271

Risk > verdict

High

Liquidity > metrics > Current Ratio

35.46747203158785

Liquidity > metrics > Quick Ratio

35.46747203158785

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

36.463335154154876

Prev Valuations > 1

40.339524481799074

Prev Valuations > 2

28.583041841085066

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-216

Prev Risks > 1

-220

Prev Risks > 2

-200

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T21:21:50.611Z